News
5 May 2020
NASAL SPRAY BIOEQUIVALENCE
In the pharmaceutical industry, we can see the development of generics is significantly growing. This trend is mainly driven by countries to give patients easier access to drugs and to define regulations accordingly.
Between-Batch Bioequivalence (BBE): An Alternative Statistical Method to Assess In Vitro Bioequivalence of Nasal Product
Mentioned Companies
Nemera
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance